GI
MED icon

GAMMA Investing’s Medifast MED Stock Holding History

GAMMA Investing’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
1,042
+137
+15% +$1.58K ﹤0.01% 3157
2026
Q1 		$9.22K Buy
905
+346
+62% +$3.73K ﹤0.01% 3108
2025
Q4 		$5.97K Sell
559
-661
-54% -$7.91K ﹤0.01% 3207
2025
Q3 		$16.7K Buy
1,220
+896
+277% +$12.5K ﹤0.01% 2611
2025
Q2 		$4.55K Buy
324
+86
+36% +$1.13K ﹤0.01% 3163
2025
Q1 		$3.21K Buy
238
+141
+145% +$2.12K ﹤0.01% 3251
2024
Q4 		$1.71K Sell
97
-560
-85% -$10.4K ﹤0.01% 3272
2024
Q3 		$12.6K Sell
657
-179
-21% -$3.45K ﹤0.01% 2353
2024
Q2 		$18.2K Buy
836
+752
+895% +$20K ﹤0.01% 1913
2024
Q1 		$3.22K Buy
84
+56
+200% +$2.71K ﹤0.01% 2579
2023
Q4 		$1.53K Buy
+28
New +$1.95K ﹤0.01% 2663

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GAMMA Investing's MED Position: Q2 2026 in Review

GAMMA Investing increased its Medifast (MED) stake by 15% in Q2 2026, buying an estimated $1.58K and bringing the position to 1,042 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3157.

GAMMA Investing first reported a position in MED in Q4 2023 and has held it in 11 quarters since. The position peaked at $18.2K in Q2 2024. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • GAMMA Investing held 1,042 shares of Medifast worth $11.1K as of Q2 2026.
  • GAMMA Investing bought 137 Medifast shares in Q2 2026, an estimated $1.58K.
  • Medifast made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3157 holding.
  • GAMMA Investing first reported a position in Medifast in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Medifast position peaked at $18.2K in Q2 2024.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.